BPH-related surgery were compared between these Gamma Secretase cancer groups and also between the patients who were considered by PV and serum PSA. In order to calculate PV, transrectal ultrasound was performed. The L Lengths and cross-face were of the L Longest cross-image of the prostate is measured. The horizontal length L Of the proximal end of the distal portion of the prostate in the analysis of sagittal than the L Length in L Longitudinal direction considered. PV to calculate the following equation was used: PV HxBxL 6x. To levels of PSA and PV strata, were their relationships with AUR and BPH related surgery analyzed by ROC curves. Among the 620 patients, go Gardens 368 to Blocking group and 252 in the combination group. In groups blockers and the combination Resp. the mean age was 64.2 years and 64.
8 years and the average follow-up was 113.1 months and 108.6 months. PSA values at the first visit of Blocking group and the combination group was 2.2 ng / ml and 2.9 ng / ml, and PV were 37.5 ml and 42.9 ml 13.6% in group blockers and 2.8% in the combination group: AUR developed in 9.2% of the entire group. Thus, the risk-money ratio combination group 79.4% lower than the Blocking group. The incidence of BPH-related surgery was 8.4% for the group -blockers And 3.2% for the combined group. Thus, the risk-money ratio combination group 61.9% lower than the Blocking group. The incidence of BPH-related surgery was 5.4% for Blocking group and 2.4% for the combination group for up to 7 years of follow-up and the difference was not significant in terms of.
For l Ngere follow-up, however, the incidence of BPH-related surgery was significantly lower in the combination group. The incidence of AUR was significantly lower in the combination group to follow periods of two years or more. The cutoff value of PSA and PV for the risk of AUR and BPH-related surgery were 2.0 ng / ml and 35 ml, if the PSA level was ng / ml of 2.0, the incidence of AUR exceeded And blocker groups combined was 24.2% and 3.8% when the PV gr Than 35 ml it is, was the H FREQUENCY of AUR 27.0% and 4.0% respectively. If the PSA level was ng / ml of 2.0, the incidence of BPH-related surgery exceeded And blocker groups combined was 17.0% and 3.8% when the PV gr Than 35 ml it is, was the H FREQUENCY of BPH-related surgery 20.6% and 4.7% respectively.
Of the 39 patients, surgery BPH related surgery RE 10 Ues because of AUR, and 29 other operations re Ues due to lack of efficacy of the drug Subjected sen treatment. BPH may have entered various complications such as AUR dinner, BPH related surgery, urinary incontinence and urinary tract infections are. Between Blockers and 5 IRA, the repr Sentative of drug Se treatment for BPH, five IRA is that they emphasized to prevent progression of BPH. In the past, but most studies were skeptical about the effects of the combination therapy Blockers and 5 IRA. The Department of Veterans Affairs Cooperative Study showed that Blocker monotherapy and polytherapy ARI 5 for 12 months reduced points of the American Urological Association symptoms to 6